Related Experiment Video
Updated: Jun 25, 2025

Analysis of Tubular Membrane Networks in Cardiac Myocytes from Atria and Ventricles
Published on: October 15, 2014
FGF13 deficiency ameliorates calcium signaling abnormality in heart failure by regulating microtubule stability
Ran Zhao1, Yingke Yan1, Yiming Dong1
1Department of Pharmacology, The Key Laboratory of Neural and Vascular Biology, Ministry of Education, The Key Laboratory of New Drug Pharmacology and Toxicology, The Hebei Collaboration Innovation Center for Mechanism, Diagnosis and Treatment of Neurological and Psychiatric Disease, Hebei Medical University, Shijiazhuang 050017, China.
Abstract:
Calcium signaling abnormality in cardiomyocytes, as a key mechanism, is closely associated with developing heart failure. Fibroblast growth factor 13 (FGF13) demonstrates important regulatory roles in the heart, but its association with cardiac calcium signaling in heart failure remains unknown. This study aimed to investigate the role and mechanism of FGF13 on calcium mishandling in heart failure. Mice underwent transaortic constriction to establish a heart failure model, which showed decreased ejection fraction, fractional shortening, and contractility. FGF13 deficiency alleviated cardiac dysfunction. Heart failure reduces calcium transients in cardiomyocytes, which were alleviated by FGF13 deficiency. Meanwhile, FGF13 deficiency restored decreased Cav1.2 and Serca2α expression and activity in heart failure. Furthermore, FGF13 interacted with microtubules in the heart, and FGF13 deficiency inhibited the increase of microtubule stability during heart failure. Finally, in isoproterenol-stimulated FGF13 knockdown neonatal rat ventricular myocytes (NRVMs), wildtype FGF13 overexpression, but not FGF13 mutant, which lost the binding site of microtubules, promoted calcium transient abnormality aggravation and Cav1.2 downregulation compared with FGF13 knockdown group. Generally, FGF13 deficiency improves abnormal calcium signaling by inhibiting the increased microtubule stability in heart failure, indicating the important role of FGF13 in cardiac calcium homeostasis and providing new avenues for heart failure prevention and treatment.
Insights
Fibroblast growth factor 13 (FGF13) deficiency improves heart failure by normalizing calcium signaling. This occurs by inhibiting increased microtubule stability, offering new therapeutic targets for heart failure.
Area of Science:
- Cardiology
- Molecular Biology
- Cellular Physiology
Background:
- Calcium signaling abnormalities in cardiomyocytes are central to heart failure development.
- Fibroblast growth factor 13 (FGF13) has known cardiac regulatory roles, but its involvement in heart failure-related calcium handling is unclear.
Purpose of the Study:
- To investigate the role and mechanism of FGF13 in cardiac calcium mishandling during heart failure.
- To determine if FGF13 influences microtubule stability in the failing heart.
Main Methods:
- A mouse model of heart failure was created using transaortic constriction.
- Cardiac function, calcium transients, Cav1.2 and Serca2α expression/activity were assessed.
- Microtubule stability was analyzed in vivo and in vitro using FGF13 knockdown and overexpression in neonatal rat ventricular myocytes (NRVMs).
Main Results:
- FGF13 deficiency alleviated cardiac dysfunction and normalized calcium transients in heart failure mice.
- FGF13 deficiency restored Cav1.2 and Serca2α expression and activity.
- FGF13 deficiency inhibited the increased microtubule stability observed in heart failure, and FGF13's microtubule-binding ability was crucial for its detrimental effects on calcium handling.
Conclusions:
- FGF13 deficiency improves cardiac calcium signaling in heart failure by inhibiting increased microtubule stability.
- FGF13 plays a critical role in cardiac calcium homeostasis and presents a potential therapeutic target for heart failure prevention and treatment.
More Related Videos
11:00Assessment of Sarcoplasmic Reticulum Calcium Reserve and Intracellular Diastolic Calcium Removal in Isolated Ventricular Cardiomyocytes
Published on: September 18, 2017
14:02Ex Vivo Assessment of Contractility, Fatigability and Alternans in Isolated Skeletal Muscles
Published on: November 1, 2012
Related Concept Videos
Microtubules in Signaling
Feedback Regulation of Calcium Concentration
Various transmembrane receptors, such as G protein-coupled receptors (GPCRs), elicit a response to extracellular signals by increasing cytosolic calcium. Activated GPCRs...
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Destabilization of Microtubules
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
Intracellular Signaling Affects Focal Adhesions
Some...